Skip to main content
. Author manuscript; available in PMC: 2018 Sep 28.
Published in final edited form as: Seizure. 2016 Nov 14;43:48–55. doi: 10.1016/j.seizure.2016.10.022

Table 1. Clinical characteristics of TEA participants.

ID Sex Age at onset Duration of attacks Approx Frequency of attacks Seizure features Other epilepsy EEG Initial treatment response
1 M 60 30-60 mins Monthly All on waking, Olf hall sps Normal Yes - LAM
2 M 49 15-30 mins Twice/month All on waking, Pure amnesia sps epileptic Yes - CBZ
3 M 68 Hrs-days No pattern On waking, Olf hall sps, cps epileptic Yes -SVP
4 F 52 2-24 hrs Twice/ yr On waking, Pure amnesia none epileptic Yes - LAM
5 M 78 Hrs-days Twice/ yr On waking none epileptic Equivocal reduction – CBZ
6 M 69 15-30 mins Monthly On waking, automatisms, déjà vu sps Non-specific abnormalities Not treated
7 M 73 1-3 hrs Monthly On waking, Pure amnesia none Non-specific abnormalities Yes - Phen
8 M 60 2-24 hrs Monthly On waking, automatisms cps, tcl (1) Normal Yes - SVP
9 M 69 20-60 mins Monthly On waking, automatisms cps Some abnormalities Yes - CBZ
10 M 52 15-30 mins Twice/wk On waking, automatisms cps, tcl (3) Some abnormalities Yes - CBZ

CBZ = carbamazepine; LAM = lamotrigine; SVP = sodium valproate; Phen = phenytoin, sps = simple partial seizures; cps = complex partial seizures; tcl = tonic-clonic seizures; Olf hall = olfactory hallucination